Lercanidipine HCl 20mg Tablets, a drug that is consumed by adults for hypertension, was recalled by the UK's MHRA over the wrong dose being printed on the box.
According to MHRA, Recordati Pharmaceuticals Limited, the manufacturer of the drug, informed of an error in the strength of the product printed on some of the faces (sides) of the product carton. The error is limited to the batch of Lercanidipine HCl 20mg Tablets.
The packs of 20mg tablets are incorrectly labelled as 10mg on some sides of the product carton. Due to this situation, a recall of the specified batch was issued as a precautionary measure.
The drug with batch number MD4L07 and expiry date of 01/2028 is the affected lot that is being recalled as a precautionary measure.
Also Read | Heatwave alert: Nagpur temperature soars, here's what to do if you are affected by heatstroke
Patients concerned they may have accidentally taken a higher dose of the medication than they were prescribed should seek medical attention. According to NHS, taking more than your prescribed dose of lercanidipine can make you feel dizzy and sleepy.
A spokeswoman for Recordati in a statement to the BBC said the company was "working proactively" with the MHRA and would be contacting customers who could have received the affected batch.
Also Read | Karnataka former DGP murder: Was his wife schizophrenic? Here's what you need to know about schizophrenia
"We are investigating the root cause and continue to work with our partners to isolate the issue and minimise disruption to our patients. Patient safety remains our top priority," she added.
